Showing results (51-60 of 89) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer CohortsArian Lundberg, Linda S Lindström, J Chuck Harrell, et al.The American Journal of Surgical Pathology|June 17, 2017
Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine SarcomasElin Hardell, Sofia Josefson, Mehran Ghaderi, et al.Genetica|May 2, 2003
Y chromosome and other heterochromatic sequences of the Drosophila melanogaster genome: how far can we go?A Bernardo Carvalho, Maria D Vibranovski, Joseph W Carlson, et al.Histopathology|December 17, 2013
Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistryMartin Köbel, Julia Bak, Björn I Bertelsen, et al.Genetics|April 26, 2011
The Drosophila gene disruption project: progress using transposons with distinctive site specificitiesHugo J Bellen, Robert W Levis, Yuchun He, et al.Nature Methods|October 11, 2011
MiMIC: a highly versatile transposon insertion resource for engineering Drosophila melanogaster genesKoen J T Venken, Karen L Schulze, Nele A Haelterman, et al.Gynecologic Oncology|October 9, 2020
High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancerSara Corvigno, Artur Mezheyeuski, Laura Martin De La Fuente, et al.Scientific Reports|December 6, 2025
Combined inhibition of NAD synthesis and C-terminal binding protein cooperatively induces cell death and inhibits growth of high grade serous ovarian carcinomaKranthi Kumar Chougoni, Jacqueline West, Nicholette St Martin, et al.Genetics|July 9, 2004
The BDGP gene disruption project: single transposon insertions associated with 40% of Drosophila genesHugo J Bellen, Robert W Levis, Guochun Liao, et al.The Journal of Pathology|December 13, 2019
Interpretation of somatic POLE mutations in endometrial carcinomaAlicia León-Castillo, Heidi Britton, Melissa K McConechy, et al.Pageof 9